[Acb-diabetics] non-invasive means of checking blood sugar

[Mike Freeman]

Kinda tough on those with artificial eyes or cataracts. (grin) Frankly, I consider that the below, like all other supposedly promising noninvasive bg measuring technologies, is little more than vaporware. These companies are, however, very good at one thing: parting unwary investors from their money!

Mike Freeman

----- Original Message -----
From: "Patricia LaFrance-Wolf" <plawolf at earthlink.net>
To: "blind diabetics of the Blind" <blind-diabetics at yahoogroups.com>, "Acb-Diabetics at Acb. Org" <acb-diabetics at acb.org>, "Doc Mahaber Dr." <trinispice at dslextreme.com>, "rayann Myers" <fuzzycyclops at charter.net>, "Joy Steigel" <jstigile at sbcglobal.net>, "Julie Cantrell" <JCantrell at juniorblind.org>
Date: Wednesday, Oct 21, 2009 17:42:51
Subject: [Acb-diabetics] non-invasive means of checking blood sugar

>
>
> 
> 
> Wonder if will be made for accessiblility?
>  
>  
> This article originally posted 20 October, 2009 and appeared in  
> Issue 491
> Glucose Levels May Be Measured Painlessly with Light in the Eye 
>  
> As with all the other companies promising a non-invasive glucose monitor, this technology has little chance for success, except for rabbits.
>  
> In pre-clinical trial Freedom Meditech technology successfully tested a new non-invasive technology designed to painlessly measure glucose levels in the
> human eye which shows promise of one day replacing the finger-stick blood test.
>  
> The study, involving rabbits, showed that the eye-scanning technology produced non-invasive, in-vivo glucose measurements that tracked blood glucose readings
> with only a five minute delay. In addition, through a calibration and validation analysis, the mean absolute percent error for glucose prediction was below
> 13%, as compared to an estimated 32% error commonly derived from the finger stick blood test. The results of the study were presented at the Biomedical
> Engineering Society`s 2009 Annual Fall Scientific Meeting. The study was conducted by Anthony J. Webb, Rui Zheng, and Brent D. Cameron of the Department
> of Bioengineering at the University of Toledo, OH.
>  
> "We are very encouraged by the results of this early-stage study and plan to move forward with additional animal studies and present the results to the
> U.S.Food and Drug Administration, in anticipation of human clinical studies," said Craig Misrach, President and CEO of Freedom Meditech. "We believe that
> the human eye represents an ideal point of access for the monitoring of bodily glucose without the interferences commonly present in other non-invasive
> glucose measurement approaches.
>  
> Freedom Meditech, Inc. is a developmental stage medical device company focused on the commercialization of novel technologies for the management of diabetes.
> The company is currently developing a patented, non-invasive ocular glucose measurement device that could provide an alternative to the finger prick method
> of diabetes blood sugar measurement and monitoring. The consumer-ready product is planned to operate like binoculars with light being shined on one eye
> for less than a second and having a digital glucose reading displayed on the device. The company is also pursuing the commercialization of a non-invasive
> ophthalmic diabetes screening device for use by eyecare professionals.
>  
> Press Release: Freedom Meditech
>  
> Positive Results for a New First in Class Diabetes Drug
> 
> _______________________________________________
> acb-diabetics mailing list
> acb-diabetics at acb.org
> http://www.acb.org/mailman/listinfo/acb-diabetics